Management of Clostridioides difficile Infection

Diagnosis and Treatment

The IDSA and SHEA guidelines recommend that patients with C. difficile infection (CDI) can be removed from isolation when they have been asymptomatic (no diarrhea) for at least 48 hours after completion of treatment with vancomycin, with the primary criterion being cessation of diarrhea, as indicated by formed or normal consistency stools and no more than 3 bowel movements in a 24-hour period 1
Approximately 25% of patients treated for CDI with vancomycin can experience at least one additional episode, with risk factors for recurrence including administration of other antibiotics during or after CDI treatment, defective immune response against C. difficile toxins, advanced age, severe underlying disease, and continued use of proton pump inhibitors 1
Standard treatment duration for CDI with vancomycin is 10 days, with clinical cure rates of 85-98%, and for patients with delayed response, extending treatment to 14 days may be considered, but there is insufficient evidence to recommend routinely extending treatment beyond 10 days for standard cases 1, 2

Patients with CDI can be removed from isolation when they have been asymptomatic (no diarrhea) for at least 48 hours after completion of treatment with vancomycin, even if they are still completing their prescribed course of vancomycin 1
Removing isolation before diarrhea has fully resolved can lead to transmission, and formed stools are the key clinical indicator 1
Keeping patients in isolation longer than necessary can negatively impact quality of life and consume healthcare resources 1

For recurrent CDI, tapered and pulsed vancomycin regimens are recommended, which would extend the treatment period but not necessarily the isolation period if symptoms have resolved 1
Molecular tests can remain positive for weeks after successful treatment, and testing asymptomatic patients can lead to overtreatment, therefore "test of cure" is not recommended after completion of treatment 1